BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 37444408)

  • 1. Insights into the Role of LncRNAs and miRNAs in Glioma Progression and Their Potential as Novel Therapeutic Targets.
    Kciuk M; Yahya EB; Mohamed MMI; Abdulsamad MA; Allaq AA; GieleciƄska A; Kontek R
    Cancers (Basel); 2023 Jun; 15(13):. PubMed ID: 37444408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long Non-Coding RNAs in Gliomas: From Molecular Pathology to Diagnostic Biomarkers and Therapeutic Targets.
    Vecera M; Sana J; Lipina R; Smrcka M; Slaby O
    Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30217088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role and clinical relevance of long non-coding RNAs in glioma.
    Gareev I; Encarnacion Ramirez MJ; Nurmukhametov R; Ivliev D; Shumadalova A; Ilyasova T; Beilerli A; Wang C
    Noncoding RNA Res; 2023 Dec; 8(4):562-570. PubMed ID: 37602320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel insights into the interaction between long non-coding RNAs and microRNAs in glioma.
    Ebrahimpour A; Sarfi M; Rezatabar S; Tehrani SS
    Mol Cell Biochem; 2021 Jun; 476(6):2317-2335. PubMed ID: 33582947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between long non-coding RNAs expression and pathogenesis and progression of gliomas.
    Zhou J; Xiang W; Li S; Hu Q; Peng T; Chen L; Ming Y
    Oncol Lett; 2018 Apr; 15(4):4070-4078. PubMed ID: 29541171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long non-coding RNAs (lncRNAs) and microRNAs regulatory pathways in the tumorigenesis and pathogenesis of glioma.
    Wu Y; Qian Z
    Discov Med; 2019 Sep; 28(153):129-138. PubMed ID: 31926584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent Insights into the Angioregulatory Role of Long Non-coding RNAs and Circular RNAs in Gliomas: From Signaling Pathways to Clinical Aspects.
    Hedayati N; Babaei Aghdam Z; Rezaee M; Mousavi Dehmordi R; Alimohammadi M; Mafi A
    Curr Med Chem; 2024 Jan; ():. PubMed ID: 38258785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long Non-Coding RNAs in Diagnosis, Treatment, Prognosis, and Progression of Glioma: A State-of-the-Art Review.
    Momtazmanesh S; Rezaei N
    Front Oncol; 2021; 11():712786. PubMed ID: 34322395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNAs in glioma progression.
    Xi J; Sun Q; Ma L; Kang J
    Cancer Lett; 2018 Apr; 419():203-209. PubMed ID: 29355660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Roles Played by Long Non-Coding RNAs in Glioma Resistance.
    Chae Y; Roh J; Kim W
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34202078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non-coding RNAs as epigenetic mediator and predictor of glioma progression, invasiveness, and prognosis.
    Zhang Y; Xiao Y; Li GC; Gong FY; Zhang XN; Hou K
    Semin Cancer Biol; 2022 Aug; 83():536-542. PubMed ID: 32920124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-coding RNAs: Regulators of glioma cell epithelial-mesenchymal transformation.
    Xin S; Huang K; Zhu XG
    Pathol Res Pract; 2019 Sep; 215(9):152539. PubMed ID: 31387808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long Non-Coding RNAs: The Key Players in Glioma Pathogenesis.
    Kiang KM; Zhang XQ; Leung GK
    Cancers (Basel); 2015 Jul; 7(3):1406-24. PubMed ID: 26230711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and validation of a novel eight mutant-derived long non-coding RNAs signature as a prognostic biomarker for genome instability in low-grade glioma.
    Maimaiti A; Wang X; Pei Y; Nuermaimaiti N; Tuersunniyazi A; Abula Y; Feng Z; Jiang L; Shi X; Kasimu M
    Aging (Albany NY); 2021 Jun; 13(11):15164-15192. PubMed ID: 34081618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roles of Long Noncoding RNAs in Conferring Glioma Progression and Treatment.
    Qin J; Jiang C; Cai J; Meng X
    Front Oncol; 2021; 11():688027. PubMed ID: 34178684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of long non-coding RNA expression profiles identifies novel lncRNA biomarkers in the tumorigenesis and malignant progression of gliomas.
    Chen G; Cao Y; Zhang L; Ma H; Shen C; Zhao J
    Oncotarget; 2017 Sep; 8(40):67744-67753. PubMed ID: 28978068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Insight into the Increasing Role of LncRNAs in the Pathogenesis of Gliomas.
    Yan Y; Xu Z; Li Z; Sun L; Gong Z
    Front Mol Neurosci; 2017; 10():53. PubMed ID: 28293170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Features of Glioma Determined and Validated Using Combined TCGA and GTEx Data Analyses.
    Yang Z; Gong W; Zhang T; Gao H
    Front Oncol; 2021; 11():729137. PubMed ID: 34660294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New insights into long noncoding RNAs and their roles in glioma.
    Peng Z; Liu C; Wu M
    Mol Cancer; 2018 Feb; 17(1):61. PubMed ID: 29458374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum microRNAs as potential noninvasive biomarkers for glioma.
    Yu X; Li Z
    Tumour Biol; 2016 Feb; 37(2):1407-10. PubMed ID: 26628296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.